Member Info for CHELSEA7

At 7.4p over on NEX. Support kicking in?

8.33%

Actual spread 2.5%......................If the MMs want to encourage trading, why not pull the SP to 7/7.40?? Maybe they will

Morning buddy. That 1291 buy, showing as a sell has your handwriting all over it??

7.20/7.80

Will take just 10k at 7.233, like yesterday

First trade a small buy at 7.411......................coming into support land?

Anyboy who checks it regularly will notice there have been no entries since June 25th-August 13th. Not for much longer I believe, financials are next week, just believe we will get very good news before that.

Today will do??

Morning All, what a strange night, for somebody who very rarely dreams, I had a mother load last night and cant really remember one that clearly, except perhaps for visions of my beloved Chelsea being taking to the sword ny Manchester United on Sunday afternoon. Fortunately, I have no expectations this year for the first time in 20 years, no trophys, but sit back and watch a team being built for the future and I must say for long periods I enjoyed it. So enough for the off topic, before i get abuse, lol.

I was talking yesterday and for a few days about research, how important it is, and how difficult it must be for some who lead very busy lives. So the secret is to find as much information, easily explained in one place, and that reminded me of a PDF filewhich having found it surprised me that it was from the Proactive one-to-one-Forum back in March 2018. I had a read through of it this morning and it really fits that criteria and reminded me about so many things which provide a fantastic explanation of our Platforms, our collaborators on each treatment and the survival rates from the SCIB1 mono trial, the wonderful data it provided, and in contrast what some would want us to believe we have no data. It is so easy to read, 23 PDF pages in large print and diagramsand so easy to understand, even I remembered most of it.

Here is the link, and Minnabo/Chester and all of us well worth the reminders it gives us...........................

https://www.proactiveinvestors.co.uk/upload/SponsorFile/File/2018_03/1520590951_Scancell---3.pdf

One example is our collaboration with BioNTech, which could well produce our first commercial deal....................
BioNTech is Europe’s largest private
biotech company
? Initial research focus on Modi-1 epitopes
(vimentin and enolase)
? Incorporates BioNTech platform for cloning
and characterisation of TCRs
? BioNTech exclusive option to license
identified TCRs
? Extensive commercial interest in T-cell
therapies e.g., Gilead’s USD11.9Bn
acquisition of Kite Pharma

Is that the kind of information that will help you? It certainly reminded me of its importance and should be just the start of Moditope updates as we draw closer to MOD1 trial which we have been looking forward too for so long.

So have a good day, and if anyone can pots links which we barely remember but need to know, please do.

ATVB

https://www.fiercebiotech.com/research/stopping-spread-pancreatic-cancer?mkt_tok=eyJpIjoiTkdZNU5HRTNOVE16TW1ZMyIsInQiOiIxTUs0aVNQY2J0WjlyM0d1Nm1Pd3dGaENzYnZWeURpeFI1OXA3QlM1OEQ4b21HRHNrK050ZUlPZlhXemVubTF1d0pxajcweUdSUXRhUGU1azJhSW1pc0U5NDFsY1k0UFpDcWhDU0E2eGUwWGNxeWhORXBuaEhjRDM2bTQrYVdaSSJ9&mrkid=36433381

Well past mine, goodnight, catch you tomorrow

Of interest.........................................

https://www.fiercebiotech.com/biotech/analysts-track-doubling-number-private-biotech-rounds?mkt_tok=eyJpIjoiTkdZNU5HRTNOVE16TW1ZMyIsInQiOiIxTUs0aVNQY2J0WjlyM0d1Nm1Pd3dGaENzYnZWeURpeFI1OXA3QlM1OEQ4b21HRHNrK050ZUlPZlhXemVubTF1d0pxajcweUdSUXRhUGU1azJhSW1pc0U5NDFsY1k0UFpDcWhDU0E2eGUwWGNxeWhORXBuaEhjRDM2bTQrYVdaSSJ9&mrkid=36433381

A big positive from the weekend that was was the depth of feeling and belief in what Scancell are trying to achieve, I think I learnt more than I ever have from fellow holders posts and their depth of feelings to what we are trying to achieve, which is not just Scancell but the progress being made in the Oncology field in the last few years.

Money is an important part of suceeding, more companies fail than those that suceed, success is not a given, and funding is we have learnt year on year in not a given. It would be easy to believe from some posts over the weekend that Scancell have no data at all. Lest we forget there are so many patients still alive 6/7 years on after being diagnosed with Stage 3/4 melanoma and given very short prognosis. T hat is the cornerstone of why we are excited about what is to come, it is not just our Science that has taken so long but the progress made in the immunotherapy field that we have adapted into our science that takes so much time.

No I don"t believe that just what we do is a good enough reason to invest, but the data we produced from the SCIB1 mono trial was compelling and I believe there is far more to come. Trading shares is not my strength or choice, unfortunately money is such an important factor, important enough for some to post very distateful posts and spreading a fear factor which may or not exist. One man has validated our thoughts, our weeks of research that many have given, and we still only know a tiny percent of what is happening in the wider world despite always keeping an eye on what is happening in the wider world.

So I make no apologies for posting again! The statement given by Martin Diggle on taking his holding of 16.67%, I believe it is no coincidence he has taken this holding now after years of research, working in our laborities and undergoing due diligence as should be the case. So it not just us who believe we are a great investment prospect, and it iws not just us who cares about cancer and the importance of the war against it, which has scarred so many of us, whether it is personally, the loss of our parents , our brothers and sisters and our friends. To read derisory comments about Scancell upset me, the case of whether we are a great investment is a very different argument .
Martin Diggle, Co-Founder and Portfolio Manager, Vulpes Investment Management, said:



"I am very pleased to be investing in Scancell at this exciting time in the company's evolution. Vulpes has been conducting scientific and commercial due diligence on Scancell for a considerable period of time. We have concluded the company's unique and innovative approach to fighting cancer is compelling and under-appreciated. At Vulpes we are always searching for overlooked companies that have the ability to make significant advances in medical science, with a view to supporting their development over the long term. We believe Scancell fulfil these criteria perfectly."

Night, I will lose no sleep!!

And so we close.

Was reading that oddmoney, 10,080 trades there today!!

Buys 67k

Sells 215k

A very quiet day, just 5 trades.............1 buy and 2 x100k sells, a peaceful day, lol, did anyone escape a warning or ban???? I hope so.

I agree with you. Even better to hear from the man himself. We have waited a long time for such an investor to come along, now wehave one and I am sure it will be the first of many. I remember a few of us saying many times that the BOD are speaking as if they know how trials will be funded, with absolute clarity and sure enough I believe this is why.

We chose the route of funding to get us here, Martin Diggles team would have known we had 2/3 years of clinical development to come. But now they are here, what does that tell us??? ATB

All very quiet here?

Minnabo was delighted that you watched Martin Diggles interview yesterday. I posted that at 6.00 yesterday morning, and it is worth hearing, so here is the link again................................

https://www.proactiveinvestors.co.uk/companies/news/313831/vulpes-life-sciences-fund-s-martin-diggle-discusses-scancell-investment-13831.html

You also got 9 recs for posting it, well done, shows us a few people watched it too, I think it had just 71 views on it yesterday morning.

You hit the nail on the head with your 19.10. Sadly nothing can be done. The positive from this weekend is the sheer number of quality reasons given why the supposed issue is not such a big issue now.

Only one person has made it an issue and one poster from ADVFN is backing him up, or should I suggest mixing it up.

Tomorrow will be interesting as I believe the issue is an excuse to report posters with strong opinions as to where there feeling lie.

Chester i so share your sentiment, Scancell and in fact any company that can save us from the sadness this disease spreads interests me and helps us understand where the different approaches lie and in every case there is a need for Approved treatments which will affect our market share commercially negligably.

Unfortunately our emotions and the fact that this share is traded, and by definition is a financial instrument, will always feel uneasy, but we are lucky we have many posters who share there knowledge so as to make our Science more understandable. Lets focus on that if it is that side which interests us as investors. A whole seperate conversation can exist running parallel to this BB which we might choose to ignore, but when the two meet lets do our part in not rising to the bait, it is a trap and we should know better.

For my part i have offered many good reasons to what may develop and backed them up, and I thank all of you for doing the same as I have learnt even more that hadnt crystslided in my head than I knew before.

Lets do our utmost not to repeat the ugly side of this weekend that is so in your face, I have chosen to filter two posters as i think i can read there every next post, so why read it and get wound up?

until tomorrow goes, deep breathes i can assure you nothing is worth the frustration or anger shared by many and nothing will bring posters not invested running back for more. SO the non issue wins again, by making nothing an issue and we should laugh and accept that is the case. I found it a pleasure posting with crumbs this morning, we werent going to rise to any bait just put forward our views and we both simultaneously stopped posting when it was done, maybe we should learn when enough is enough as the day has progressed into a brawl and abuse and it need never be.'

Another new week, expecting new news and it is the market that will take us forward as they have done from 3.7-9.5p. Much to look forward too that hasn"t changed but something must give as to how we react, it is all a test with agendas in place, I guarantee you all of that.

Goodnight All new day, new way, chill and feel proud of the good stuff there was plenty to see, C7

So glad this Vulpes issue has been brought up again, a few months ago we were saying when discussing BioNTech, how wonderful it would be to be involved with a company who could financially pull us through the clinical development of our pipelines into human trials. Whether it be by further stake building, loan faciities or other investors taking stakes, that is exactly what we have. Is it any wonder our shares doubled, 10p was paid, on the Vulpes news!!??

Something I picked up from the interview on Proactive with Martin Diggle (posted this morning) was that Mr Science Guy spent some considerable time with Lindy in the laborities prior to the deal with Scancell, so no doubt that will continue ""for the long term"

Well it is something that was spoken about yesterday again. I think that the key in persuading Scancell to accept 5p a share for a 16.67% stake, is in what they will bring to the table as we develop the pipelines further. Yes that is an option, but wouldn"t a loan facility depend upon some form of income for now??

And of course, ignoring this................................

Martin Diggle, Co-Founder and Portfolio Manager, Vulpes Investment Management, said:



"I am very pleased to be investing in Scancell at this exciting time in the company's evolution. Vulpes has been conducting scientific and commercial due diligence on Scancell for a considerable period of time. We have concluded the company's unique and innovative approach to fighting cancer is compelling and under-appreciated. At Vulpes we are always searching for overlooked companies that have the ability to make significant advances in medical science, with a view to supporting their development over the long term. We believe Scancell fulfil these criteria perfectly."

LOL

I like this part, something we were discussing yesterday and could partially explain the beginning of building of holdings in recent weeks

Conviction: All of our investments are backed with a substantial amount of the partners’ capital, and everything we invest in is available to outside investors.

Stakis, Yep, I am hoping we get news on the SCIB1 trial starting by then. The press have a habit of headlining "Scancell make record losses"" news that the trial is underway will certainly quell that.